Pfizer Inc Stock Return On Asset

PFE Stock  USD 27.78  0.19  0.69%   
Pfizer Inc fundamentals help investors to digest information that contributes to Pfizer's financial success or failures. It also enables traders to predict the movement of Pfizer Stock. The fundamental analysis module provides a way to measure Pfizer's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pfizer stock.
As of March 28, 2024, Return On Assets is expected to decline to 0.01.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Pfizer Return On Asset Analysis

Pfizer's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
 2021 2022 2023 2024 (projected)
Gross Profit50.5B66.0B29.3B30.4B
Total Revenue81.3B100.3B58.5B39.5B

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Pfizer Return On Asset

    
  0.0155  
Most of Pfizer's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pfizer Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Pfizer Return On Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for Pfizer is extremely important. It helps to project a fair market value of Pfizer Stock properly, considering its historical fundamentals such as Return On Asset. Since Pfizer's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pfizer's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pfizer's interrelated accounts and indicators.
0.70.770.820.770.540.6-0.120.980.640.350.870.840.870.30.910.40.40.880.79-0.610.320.440.480.060.54-0.280.080.21-0.140.45-0.36-0.4
0.70.520.610.790.340.72-0.440.640.36-0.120.490.580.890.120.540.020.730.710.45-0.63-0.240.850.60.340.71-0.640.27-0.02-0.30.6-0.27-0.52
0.770.520.370.550.720.20.080.680.860.210.550.920.620.590.810.30.480.480.78-0.430.260.290.27-0.070.34-0.150.09-0.04-0.170.280.010.2
0.820.610.370.790.110.83-0.440.880.150.510.810.580.8-0.190.680.340.310.960.68-0.70.230.460.620.420.68-0.470.060.55-0.130.62-0.7-0.59
0.770.790.550.790.130.79-0.710.760.280.280.540.630.920.010.780.310.470.80.73-0.950.150.680.640.210.93-0.680.240.32-0.540.46-0.41-0.47
0.540.340.720.110.13-0.220.460.460.730.050.410.720.350.420.520.210.30.250.460.010.390.040.27-0.23-0.08-0.01-0.05-0.14-0.04-0.040.160.16
0.60.720.20.830.79-0.22-0.640.62-0.030.120.560.310.76-0.210.410.010.50.830.38-0.69-0.230.770.470.580.75-0.560.250.25-0.130.76-0.64-0.69
-0.12-0.440.08-0.44-0.710.46-0.64-0.170.34-0.170.05-0.05-0.480.4-0.21-0.12-0.24-0.35-0.290.820.1-0.53-0.49-0.36-0.890.71-0.28-0.410.57-0.280.340.34
0.980.640.680.880.760.460.62-0.170.550.460.890.80.840.20.90.50.310.910.81-0.640.380.380.50.10.56-0.250.050.33-0.080.45-0.42-0.42
0.640.360.860.150.280.73-0.030.340.550.030.380.710.380.850.70.180.210.290.53-0.170.30.090.0-0.350.040.110.03-0.280.02-0.030.330.2
0.35-0.120.210.510.280.050.12-0.170.460.030.430.370.2-0.210.430.66-0.140.320.65-0.370.48-0.390.180.040.250.03-0.180.86-0.090.18-0.450.15
0.870.490.550.810.540.410.560.050.890.380.430.670.730.050.680.450.350.820.64-0.360.240.240.450.180.32-0.11-0.230.350.050.56-0.49-0.42
0.840.580.920.580.630.720.31-0.050.80.710.370.670.720.330.870.480.460.650.9-0.550.390.310.510.090.47-0.260.040.18-0.160.35-0.150.08
0.870.890.620.80.920.350.76-0.480.840.380.20.730.720.040.760.320.630.860.71-0.780.070.690.690.260.8-0.620.070.26-0.410.58-0.38-0.51
0.30.120.59-0.190.010.42-0.210.40.20.85-0.210.050.330.040.39-0.02-0.02-0.070.160.060.06-0.06-0.31-0.54-0.170.330.08-0.50.1-0.230.550.29
0.910.540.810.680.780.520.41-0.210.90.70.430.680.870.760.390.570.210.720.9-0.730.570.280.46-0.160.59-0.250.080.24-0.280.15-0.15-0.17
0.40.020.30.340.310.210.01-0.120.50.180.660.450.480.32-0.020.57-0.160.250.66-0.420.55-0.280.26-0.260.320.14-0.320.47-0.09-0.070.020.13
0.40.730.480.310.470.30.5-0.240.310.21-0.140.350.460.63-0.020.21-0.160.40.3-0.31-0.430.650.460.490.43-0.520.01-0.01-0.240.67-0.2-0.13
0.880.710.480.960.80.250.83-0.350.910.290.320.820.650.86-0.070.720.250.40.67-0.670.210.590.610.420.65-0.490.140.35-0.080.61-0.61-0.62
0.790.450.780.680.730.460.38-0.290.810.530.650.640.90.710.160.90.660.30.67-0.730.510.170.540.090.63-0.31-0.030.5-0.270.3-0.240.07
-0.61-0.63-0.43-0.7-0.950.01-0.690.82-0.64-0.17-0.37-0.36-0.55-0.780.06-0.73-0.42-0.31-0.67-0.73-0.25-0.54-0.62-0.17-0.970.65-0.24-0.420.56-0.30.320.33
0.32-0.240.260.230.150.39-0.230.10.380.30.480.240.390.070.060.570.55-0.430.210.51-0.25-0.370.21-0.440.060.08-0.150.31-0.17-0.520.050.08
0.440.850.290.460.680.040.77-0.530.380.09-0.390.240.310.69-0.060.28-0.280.650.590.17-0.54-0.370.430.490.66-0.660.49-0.24-0.230.58-0.34-0.58
0.480.60.270.620.640.270.47-0.490.50.00.180.450.510.69-0.310.460.260.460.610.54-0.620.210.430.360.67-0.73-0.160.46-0.510.3-0.32-0.37
0.060.34-0.070.420.21-0.230.58-0.360.1-0.350.040.180.090.26-0.54-0.16-0.260.490.420.09-0.17-0.440.490.360.33-0.470.140.260.210.77-0.58-0.19
0.540.710.340.680.93-0.080.75-0.890.560.040.250.320.470.8-0.170.590.320.430.650.63-0.970.060.660.670.33-0.750.240.39-0.560.42-0.36-0.38
-0.28-0.64-0.15-0.47-0.68-0.01-0.560.71-0.250.110.03-0.11-0.26-0.620.33-0.250.14-0.52-0.49-0.310.650.08-0.66-0.73-0.47-0.75-0.15-0.260.66-0.350.310.41
0.080.270.090.060.24-0.050.25-0.280.050.03-0.18-0.230.040.070.080.08-0.320.010.14-0.03-0.24-0.150.49-0.160.140.24-0.15-0.250.070.13-0.33-0.16
0.21-0.02-0.040.550.32-0.140.25-0.410.33-0.280.860.350.180.26-0.50.240.47-0.010.350.5-0.420.31-0.240.460.260.39-0.26-0.25-0.280.25-0.56-0.06
-0.14-0.3-0.17-0.13-0.54-0.04-0.130.57-0.080.02-0.090.05-0.16-0.410.1-0.28-0.09-0.24-0.08-0.270.56-0.17-0.23-0.510.21-0.560.660.07-0.280.110.010.14
0.450.60.280.620.46-0.040.76-0.280.45-0.030.180.560.350.58-0.230.15-0.070.670.610.3-0.3-0.520.580.30.770.42-0.350.130.250.11-0.67-0.31
-0.36-0.270.01-0.7-0.410.16-0.640.34-0.420.33-0.45-0.49-0.15-0.380.55-0.150.02-0.2-0.61-0.240.320.05-0.34-0.32-0.58-0.360.31-0.33-0.560.01-0.670.49
-0.4-0.520.2-0.59-0.470.16-0.690.34-0.420.20.15-0.420.08-0.510.29-0.170.13-0.13-0.620.070.330.08-0.58-0.37-0.19-0.380.41-0.16-0.060.14-0.310.49
Click cells to compare fundamentals
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Pfizer Total Assets

Total Assets

237.83 Billion

At present, Pfizer's Total Assets are projected to increase significantly based on the last few years of reporting.
Based on the latest financial disclosure, Pfizer Inc has a Return On Asset of 0.0155. This is 100.18% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The return on asset for all United States stocks is 111.07% lower than that of the firm.

Pfizer Return On Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pfizer's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pfizer could also be used in its relative valuation, which is a method of valuing Pfizer by comparing valuation metrics of similar companies.
Pfizer is currently under evaluation in return on asset category among related companies.

Pfizer ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Pfizer's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Pfizer's managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Pfizer Fundamentals

About Pfizer Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Pfizer Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pfizer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pfizer Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Return On Assets 0.01  0.01 

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pfizer Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:
Check out Pfizer Piotroski F Score and Pfizer Altman Z Score analysis.
Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Pfizer Stock analysis

When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.76)
Dividend Share
1.64
Earnings Share
0.37
Revenue Per Share
10.366
Quarterly Revenue Growth
(0.41)
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.